Shock Wave Versus Vacuum Assisted Closure on Chronic Diabetic Foot Ulcer

May 5, 2023 updated by: Shaimaa Mohamed Ahmed Elsayeh, Cairo University

Shock Wave Versus Vacuum-assisted Closure on Chronic Diabetic Foot Ulcer

This study will be a randomized, open-label, pretest post-test with two study groups.

Study Overview

Detailed Description

The randomization procedure will be performed by a simple drawing of lots (A or B) which determined whether participants would receive Shock wave therapy ( group A) or vacuum-assisted closure therapy (group B). Patients in both groups will receive the same medical treatment and nursing care.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 02
        • Shaimaa Mohamed Ahmed El Sayeh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

All patients had chronic diabetic foot ulcers that did not heal within six weeks of the incidence.

Exclusion Criteria:

Patients with acute cellulitis, osteomyelitis, or gangrene anywhere in the affected extremity.

Patients with renal, hepatic, neurological, or malignant diseases.

Patients with severe protein malnutrition (serum albumin < 2.0 g/dl) or severe anemia (Hgb < 7.0 g/dl).

Patients with an ankle-brachial index < 0.7, absence of the dorsalis pedis or posterior tibial artery pulse.

Patients who had debridement; pregnancy.

Patients who refused to join the study, or to sign the written consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Shock wave therapy group
Patients in this group were managed by shock wave therapy, using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session, for six weeks
using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session for 6 weeks.
Other Names:
  • Traditional medical and wound care
Active Comparator: Vacuum-assisted closure group
the patients in this group were treated by vacuum-assisted closure using KCI's Vacuum Assisted Closure Device, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, The dressings were changed on the fourth day.
Using KCI's Vacuum Assisted Closure Device for six weeks, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, the dressings were changed on the fourth day.
Other Names:
  • Traditional medical and wound care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound surface area
Time Frame: change from baseline and after six weeks of intervention.
using the ruler method to to measure the longest length and the widest width and multiplying them.
change from baseline and after six weeks of intervention.
Wound volume
Time Frame: change from baseline and after six weeks of intervention.
using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.
change from baseline and after six weeks of intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound surface area
Time Frame: change from baseline and after two weeks of intervention.
using the ruler method to to measure the longest length and the widest width and multiplying them.
change from baseline and after two weeks of intervention.
Wound surface area
Time Frame: change from baseline and after four weeks of intervention.
using the ruler method to to measure the longest length and the widest width and multiplying them.
change from baseline and after four weeks of intervention.
Wound volume
Time Frame: change from baseline and after two weeks of intervention.
using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.
change from baseline and after two weeks of intervention.
Wound volume
Time Frame: change from baseline and after four weeks of intervention.
using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.
change from baseline and after four weeks of intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Shaimaa MA El Sayeh, PhD, Lecturer at Faculty of Physical Therapy, Cairo University
  • Principal Investigator: Nesrein A Abdel Rashed, PhD, Assistant Professor at Faculty of Physical Therapy, Cairo University
  • Principal Investigator: Hamada A Hamada, PhD, Assistant Professor at Faculty of Physical Therapy, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2022

Primary Completion (Actual)

February 14, 2023

Study Completion (Actual)

April 15, 2023

Study Registration Dates

First Submitted

April 24, 2023

First Submitted That Met QC Criteria

May 5, 2023

First Posted (Actual)

May 9, 2023

Study Record Updates

Last Update Posted (Actual)

May 9, 2023

Last Update Submitted That Met QC Criteria

May 5, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Diabetic Foot Ulcer

Clinical Trials on Shock wave therapy

3
Subscribe